FIELD: medicine.
SUBSTANCE: autophagy inhibitor based on thioxanthone is used to manufacture a medicament for cancer treatment in combination with an autophagy-causing compound. A pharmaceutical composition and a pharmaceutical kit for cancer treatment containing an autophagy inhibitor based on thioxanthone and an autophagic compound are also provided.
EFFECT: increased anticancer activity of therapy due to decreased cell viability and increased apoptosis.
8 cl, 26 dwg, 7 ex
| Title |
Year |
Author |
Number |
| DOSAGE FORMS OF HISTONE DEACETYLASE INHIBITOR IN COMBINATION WITH BENDAMUSTINE AND THEIR APPLICATION |
2011 |
- Lauri Devid Dzh.
- Bagi Dzhozef Dzh.
- Modi Tarak D.
- Verner Erik Dzh.
- Purro Norbert
- Balasubramanian Sriram
- Kloos Joanna
- Depil Stefan
|
RU2609833C2 |
| TREATMENT OF CANCER, USING ANTIBODY TO SEMAPHORIN 4D IN COMBINATION WITH EPIGENETIC MODULATING AGENT |
2018 |
- Evans, Elizabet
- Smit, Ernest S.
- Zauderer, Moris
|
RU2783535C2 |
| COMBINATION OF A HISTONE DEACETYLASE INHIBITOR AND A PROTEIN KINASE INHIBITOR AND PHARMACEUTICAL APPLICATION THEREOF |
2019 |
- Lu, Xianping
- Ning, Zhiqiang
- Zhou, You
- Xin, Lijun
- Wang, Yanan
- Wang, Shigang
- Pan, Desi
- Shan, Song
|
RU2770754C1 |
| MACROCYCLIC COMPOUNDS, APPLIED AS HISTONE DEACETYLASE INHIBITORS |
2011 |
- Lju Sjuehdun
- Fillips Ehndrju Dzh.
- Ungermannova Dana
- Nasveschuk Kristofer G.
- Chzhan Gan
|
RU2565076C2 |
| PHARMACEUTICAL COMBINATIONS OF HISTONE DEACETYLASE INHIBITOR AND PROTEASOME INHIBITOR OR IMMUNOMODULATORY DRUG FOR TREATING BLOOD CANCER |
2017 |
|
RU2721409C1 |
| METHODS OF REDUCING CACHEXIA ASSOCIATED WITH CANCER |
2014 |
- Chen Chin-Shikh
- Bekaii-Saab Tanios
- Gattridzh Denis
- Markuchchi Gvido
- Kalp Samyuel
- Tsen Yuj-Chou
|
RU2692785C1 |
| COMBINATIONS OF SPECIFIC CLASS I HISTONE DEACETYLASE INHIBITORS AND PROTEASOME INHIBITORS |
2007 |
- Arts Janine
- Khellemans Peter Villem Jan
- Zhaniko Mishel' Mari Fransua
- Pehjdzh Martin Dzhon
|
RU2456990C2 |
| NOVEL APPROACH TO CANCER TREATMENT USING IMMUNOMODULATION |
2016 |
- Mehta, Vimal D.
- Rastelli, Luca
- Sapra, Aparna Katoch
|
RU2817047C2 |
| COMBINED THERAPY WITH TETRACYCLIC QUINOLONE ANALOGUES FOR CANCER TREATMENT |
2016 |
|
RU2752506C2 |
| COMBINATION THERAPY WITH TETRACYCLIC QUINOLONE ANALOGUES FOR TREATMENT OF CANCER |
2016 |
|
RU2786570C2 |
